Minimal residual disease in cervical cancer: biological persistence, ctHPV DNA-guided surveillance, and recurrence-directed intervention
Cervical cancer remains a leading cause of cancer-related mortality among women worldwide, with approximately 30–40% of patients experiencing recurrence after definitive chemoradiotherapy for locally advanced disease. The concept of minimal residual disease (MRD)—the persistence of viable tumor clones after curative-in...